Hind Nassar Warzecha

472 total citations
7 papers, 347 citations indexed

About

Hind Nassar Warzecha is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Hind Nassar Warzecha has authored 7 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Hind Nassar Warzecha's work include Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (3 papers) and Cancer Cells and Metastasis (3 papers). Hind Nassar Warzecha is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (3 papers) and Cancer Cells and Metastasis (3 papers). Hind Nassar Warzecha collaborates with scholars based in Germany and United States. Hind Nassar Warzecha's co-authors include Hillary Elwood, Ashley Cimino‐Mathews, Rajni Sharma, Pedram Argani, Janis M. Taube, Peter B. Illei, Ben Ho Park, Andrea P. Subhawong, Leisha A. Emens and Elizabeth D. Thompson and has published in prestigious journals such as Human Pathology, Breast Cancer Research and Treatment and Modern Pathology.

In The Last Decade

Hind Nassar Warzecha

7 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hind Nassar Warzecha Germany 6 186 107 74 73 59 7 347
Ehab Husain United Kingdom 11 135 0.7× 129 1.2× 118 1.6× 38 0.5× 51 0.9× 25 398
M. Rudas Austria 9 156 0.8× 177 1.7× 88 1.2× 43 0.6× 169 2.9× 24 412
B. Högel Germany 6 300 1.6× 243 2.3× 144 1.9× 48 0.7× 100 1.7× 11 476
Ji Won Woo South Korea 10 219 1.2× 118 1.1× 82 1.1× 49 0.7× 41 0.7× 18 352
Eduardas Aleknavičius Lithuania 10 101 0.5× 79 0.7× 94 1.3× 36 0.5× 40 0.7× 33 386
Patrick Tas France 10 91 0.5× 129 1.2× 66 0.9× 49 0.7× 137 2.3× 31 319
Marcella Marconi Italy 13 401 2.2× 152 1.4× 76 1.0× 139 1.9× 53 0.9× 15 526
Grazia Maria Vernaci Italy 11 408 2.2× 250 2.3× 69 0.9× 30 0.4× 32 0.5× 27 525
Takaharu Hatano Japan 10 270 1.5× 109 1.0× 46 0.6× 87 1.2× 17 0.3× 23 366
Muy‐Kheng M. Tea Austria 9 145 0.8× 150 1.4× 72 1.0× 11 0.2× 121 2.1× 16 435

Countries citing papers authored by Hind Nassar Warzecha

Since Specialization
Citations

This map shows the geographic impact of Hind Nassar Warzecha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hind Nassar Warzecha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hind Nassar Warzecha more than expected).

Fields of papers citing papers by Hind Nassar Warzecha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hind Nassar Warzecha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hind Nassar Warzecha. The network helps show where Hind Nassar Warzecha may publish in the future.

Co-authorship network of co-authors of Hind Nassar Warzecha

This figure shows the co-authorship network connecting the top 25 collaborators of Hind Nassar Warzecha. A scholar is included among the top collaborators of Hind Nassar Warzecha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hind Nassar Warzecha. Hind Nassar Warzecha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hahn, Markus, Birgitt Schoenfisch, Ines Gruber, et al.. (2018). High intensity focused ultrasound (HIFU) for the treatment of symptomatic breast fibroadenoma. International Journal of Hyperthermia. 35(1). 463–470. 23 indexed citations
2.
Warzecha, Hind Nassar, Falko Fend, Julia Steinhilber, et al.. (2017). Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(3). 347–353. 1 indexed citations
3.
Thompson, Elizabeth D., Janis M. Taube, Hillary Elwood, et al.. (2016). The immune microenvironment of breast ductal carcinoma in situ. Modern Pathology. 29(3). 249–258. 116 indexed citations
4.
VandenBussche, Christopher J., et al.. (2013). Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype. Human Pathology. 44(11). 2487–2493. 14 indexed citations
6.
Cimino‐Mathews, Ashley, Andrea P. Subhawong, Hillary Elwood, et al.. (2012). Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. Human Pathology. 44(6). 959–965. 122 indexed citations
7.
Jacobs, Michael A., Ronald Ouwerkerk, Antonio C. Wolff, et al.. (2011). Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer. Breast Cancer Research and Treatment. 128(1). 119–126. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026